119 related articles for article (PubMed ID: 30002362)
41. Minimum graft size calculated from preoperative recipient status in living donor liver transplantation.
Marubashi S; Nagano H; Eguchi H; Wada H; Asaoka T; Tomimaru Y; Tomokuni A; Umeshita K; Doki Y; Mori M
Liver Transpl; 2016 May; 22(5):599-606. PubMed ID: 26684397
[TBL] [Abstract][Full Text] [Related]
42. Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects.
Giovannini S; Tinelli G; Biscetti F; Straface G; Angelini F; Pitocco D; Mucci L; Landolfi R; Flex A
Cardiovasc Diabetol; 2017 Aug; 16(1):99. PubMed ID: 28789654
[TBL] [Abstract][Full Text] [Related]
43. Interferon-γ, interleukin-10 and interferon-inducible protein 10 (CXCL10) as serum biomarkers for the early allograft dysfunction after liver transplantation.
Karakhanova S; Oweira H; Steinmeyer B; Sachsenmaier M; Jung G; Elhadedy H; Schmidt J; Hartwig W; Bazhin AV; Werner J
Transpl Immunol; 2016 Feb; 34():14-24. PubMed ID: 26658573
[TBL] [Abstract][Full Text] [Related]
44. The clinical relevance of the anhepatic phase during liver transplantation.
Ijtsma AJ; van der Hilst CS; de Boer MT; de Jong KP; Peeters PM; Porte RJ; Slooff MJ
Liver Transpl; 2009 Sep; 15(9):1050-5. PubMed ID: 19718649
[TBL] [Abstract][Full Text] [Related]
45. Clinical significance of lactate clearance for the development of early allograft dysfunction and short-term prognosis in deceased donor liver transplantation.
Kim DG; Lee JY; Jung YB; Song SH; Lee JG; Han DH; Joo DJ; Ju MK; Choi GH; Choi JS; Kim MS; Kim SI
Clin Transplant; 2017 Dec; 31(12):. PubMed ID: 29032588
[TBL] [Abstract][Full Text] [Related]
46. The postoperative Model for End stage Liver Disease score as a predictor of short-term outcome after transplantation of extended criteria donor livers.
Benko T; Gallinat A; Minor T; Saner FH; Sotiropoulos GC; Paul A; Hoyer DP
Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):716-722. PubMed ID: 28441690
[TBL] [Abstract][Full Text] [Related]
47. A novel prognostic model based on serum levels of total bilirubin and creatinine early after liver transplantation.
Xu X; Ling Q; Wu J; Chen J; Gao F; Feng XN; Zheng SS
Liver Int; 2007 Aug; 27(6):816-24. PubMed ID: 17617125
[TBL] [Abstract][Full Text] [Related]
48. Graft selection strategy in adult-to-adult living donor liver transplantation: When both hemiliver grafts meet volumetric criteria.
Kurihara T; Yoshizumi T; Yoshida Y; Ikegami T; Itoh S; Harimoto N; Ninomiya M; Uchiyama H; Okabe H; Kimura K; Kawanaka H; Shirabe K; Maehara Y
Liver Transpl; 2016 Jul; 22(7):914-22. PubMed ID: 26953726
[TBL] [Abstract][Full Text] [Related]
49. Effects of therapeutic plasma exchange on early allograft dysfunction after liver transplantation.
Choe W; Kwon SW; Kim SS; Hwang S; Song GW; Lee SG
J Clin Apher; 2017 Jun; 32(3):147-153. PubMed ID: 27306278
[TBL] [Abstract][Full Text] [Related]
50. Avoiding Futility in Simultaneous Liver-kidney Transplantation: Analysis of 331 Consecutive Patients Listed for Dual Organ Replacement.
Lunsford KE; Bodzin AS; Markovic D; Zarrinpar A; Kaldas FM; Gritsch HA; Xia V; Farmer DG; Danovitch GM; Hiatt JR; Busuttil RW; Agopian VG
Ann Surg; 2017 May; 265(5):1016-1024. PubMed ID: 27232249
[TBL] [Abstract][Full Text] [Related]
51. Effect of early allograft dysfunction on outcomes following liver transplantation.
Hudcova J; Scopa C; Rashid J; Waqas A; Ruthazer R; Schumann R
Clin Transplant; 2017 Feb; 31(2):. PubMed ID: 28004856
[TBL] [Abstract][Full Text] [Related]
52. High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis.
Kokkola R; Sundberg E; Ulfgren AK; Palmblad K; Li J; Wang H; Ulloa L; Yang H; Yan XJ; Furie R; Chiorazzi N; Tracey KJ; Andersson U; Harris HE
Arthritis Rheum; 2002 Oct; 46(10):2598-603. PubMed ID: 12384917
[TBL] [Abstract][Full Text] [Related]
53. Coexistence of Bilirubin ≥10 mg/dL and Prothrombin Time-International Normalized Ratio ≥1.6 on Day 7: A Strong Predictor of Early Graft Loss After Living Donor Liver Transplantation.
Okamura Y; Yagi S; Sato T; Hata K; Ogawa E; Yoshizawa A; Kamo N; Yamashiki N; Okajima H; Kaido T; Uemoto S
Transplantation; 2018 Mar; 102(3):440-447. PubMed ID: 28968350
[TBL] [Abstract][Full Text] [Related]
54. Plasma concentrations and importance of High Mobility Group Box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation.
Hatada T; Wada H; Nobori T; Okabayashi K; Maruyama K; Abe Y; Uemoto S; Yamada S; Maruyama I
Thromb Haemost; 2005 Nov; 94(5):975-9. PubMed ID: 16363239
[TBL] [Abstract][Full Text] [Related]
55. Donor and recipient selection leads to good patient and graft outcomes for right lobe split transplantation versus whole graft liver transplantation in adult recipients.
Sandroussi C; Crawford M; Lockwood DS; Tang P; Gallagher JP; Pleass H; Strasser SI; Shackel NA; McCaughan GW; Verran DJ
Liver Transpl; 2009 Nov; 15(11):1586-93. PubMed ID: 19877214
[TBL] [Abstract][Full Text] [Related]
56. High-mobility group box chromosomal protein 1 as a potential inflammatory biomarker of joint injury in Thoroughbreds.
Brown MP; Trumble TN; Merritt KA
Am J Vet Res; 2009 Oct; 70(10):1230-5. PubMed ID: 19795937
[TBL] [Abstract][Full Text] [Related]
57. Prediction of Graft Survival Post-liver Transplantation by L-GrAFT Risk Score Model, EASE Score, MEAF Scoring, and EAD.
Chen S; Wang T; Luo T; He S; Huang C; Jia Z; Zhan L; Wang D; Zhu X; Guo Z; He X
Front Surg; 2021; 8():753056. PubMed ID: 34869560
[No Abstract] [Full Text] [Related]
58. Donor Indocyanine Green Clearance Test Predicts Graft Quality and Early Graft Prognosis After Liver Transplantation.
Tang Y; Han M; Chen M; Wang X; Ji F; Zhao Q; Zhang Z; Ju W; Wang D; Guo Z; He X
Dig Dis Sci; 2017 Nov; 62(11):3212-3220. PubMed ID: 28932926
[TBL] [Abstract][Full Text] [Related]
59. Elevated Serum High-Mobility Group Box-1 Protein Level Is Associated with Poor Functional Outcome in Ischemic Stroke.
Tsukagawa T; Katsumata R; Fujita M; Yasui K; Akhoon C; Ono K; Dohi K; Aruga T
J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2404-2411. PubMed ID: 28645523
[TBL] [Abstract][Full Text] [Related]
60. A novel objective method for deceased donor and recipient size matching in liver transplantation.
Croome KP; Lee DD; Saucedo-Crespo H; Burns JM; Nguyen JH; Perry DK; Taner CB
Liver Transpl; 2015 Dec; 21(12):1471-7. PubMed ID: 26358746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
